Extended treatment of older cigarette smokers.

AIMS Tobacco dependence treatments achieve abstinence rates of 25-30% at 1 year. Low rates may reflect failure to conceptualize tobacco dependence as a chronic disorder. The aims of the present study were to determine the efficacy of extended cognitive behavioral and pharmacological interventions in smokers > or = 50 years of age, and to determine if gender differences in efficacy existed. DESIGN Open randomized clinical trial. SETTING A free-standing, smoking treatment research clinic. PARTICIPANTS A total of 402 smokers of > or = 10 cigarettes per day, all 50 years of age or older. INTERVENTION Participants completed a 12-week treatment that included group counseling, nicotine replacement therapy (NRT) and bupropion. Participants, independent of smoking status, were then assigned randomly to follow-up conditions: (i) standard treatment (ST; no further treatment); (ii) extended NRT (E-NRT; 40 weeks of nicotine gum availability); (iii) extended cognitive behavioral therapy (E-CBT; 11 cognitive behavioral sessions over a 40-week period); or (iv) E-CBT plus E-NRT (E-combined; 11 cognitive behavioral sessions plus 40 weeks nicotine gum availability). MEASUREMENTS Primary outcome variable was 7-day point prevalence cigarette abstinence verified biochemically at weeks 24, 52, 64 and 104. FINDINGS The most clinically important findings were significant main effects for treatment condition, time and the treatment x time interaction. The E-CBT condition produced high cigarette abstinence rates that were maintained throughout the 2-year study period [(week 24 (58%), 52 (55%), 64 (55%) and 104 (55%)], and was significantly more effective than E-NRT and ST across that period. No other treatment condition was significantly different to ST. No effects for gender were found. CONCLUSIONS Extended cognitive behavioral treatments can produce high and stable cigarette abstinence rates for both men and women. NRT does not add to the efficacy of extended CBT, and may hamper its efficacy. Research is needed to determine if these results can be replicated in a sample with a greater range of ages, and improved upon with the addition of medications other than NRT.

[1]  Daniel L. Segal,et al.  Diagnostic Interview Schedule for DSM-IV (DIS-IV) , 2010 .

[2]  A. Schatzberg,et al.  Extended cognitive behavior therapy for cigarette smoking cessation. , 2008, Addiction.

[3]  Dependence Update Panel,et al.  A clinical practice guideline for treating tobacco use and dependence: 2008 update. A U.S. Public Health Service report. , 2008, American journal of preventive medicine.

[4]  Tobacco Use and Dependence Guideline Panel.  Treating Tobacco Use and Dependence: 2008 Update , 2008 .

[5]  C. Billing,et al.  A double-blind study evaluating the long-term safety of varenicline for smoking cessation* , 2007, Current medical research and opinion.

[6]  S. Tonstad,et al.  Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. , 2006, JAMA.

[7]  A. Schatzberg,et al.  Extended treatment with bupropion SR for cigarette smoking cessation. , 2006, Journal of consulting and clinical psychology.

[8]  S. Hall,et al.  Extended nortriptyline and psychological treatment for cigarette smoking. , 2004, The American journal of psychiatry.

[9]  A. Buist,et al.  Efficacy of bupropion for relapse prevention in smokers with and without a past history of major depression , 2004, Journal of General Internal Medicine.

[10]  I Campbell,et al.  Nicotine replacement therapy in smoking cessation. , 2003, Thorax.

[11]  R. Hurt,et al.  Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  S. Hall,et al.  Anabasine and anatabine as biomarkers for tobacco use during nicotine replacement therapy. , 2002, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[13]  W. Velicer,et al.  Biochemical verification of tobacco use and cessation. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[14]  M. Fiore,et al.  Treating tobacco use and dependence: an evidence-based clinical practice guideline for tobacco cessation. , 2002, Chest.

[15]  David Satcher,et al.  Women and smoking: a report of the Surgeon General. , 2002, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

[16]  A. Buist,et al.  Sustained-Release Bupropion for Pharmacologic Relapse Prevention after Smoking Cessation , 2001, Annals of Internal Medicine.

[17]  D. Moher,et al.  The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and Elaboration , 2001, Annals of Internal Medicine.

[18]  James A. Blumenthal,et al.  Exercise Treatment for Major Depression: Maintenance of Therapeutic Benefit at 10 Months , 2000, Psychosomatic medicine.

[19]  Richard Doll,et al.  Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies , 2000, BMJ : British Medical Journal.

[20]  Michael C. Fiore,et al.  A Clinical Practice Guideline for Treating Tobacco Use and Dependence A US Public Health Service Report , 2000 .

[21]  K. Krishnan,et al.  Effects of exercise training on older patients with major depression. , 1999, Archives of internal medicine.

[22]  C. Husten,et al.  Cigarette smoking and smoking cessation among older adults: United States, 1965-94. , 1997, Tobacco control.

[23]  D. Ossip-Klein,et al.  Self-help interventions for older smokers. , 1997, Tobacco control.

[24]  E. Perez-stable,et al.  Mood Management Mail Intervention Increases Abstinence Rates for Spanish-Speaking Latino Smokers , 1997, American journal of community psychology.

[25]  J Rochon,et al.  Application of GEE procedures for sample size calculations in repeated measures experiments. , 1997, Statistics in medicine.

[26]  S. Hall,et al.  Mood management and nicotine gum in smoking treatment: a therapeutic contact and placebo-controlled study. , 1996, Journal of consulting and clinical psychology.

[27]  N. Benowitz,et al.  The Benefits of Stopping Smoking and the Role of Nicotine Replacement Therapy in Older Patients , 1996, Drugs & aging.

[28]  B. Rimer,et al.  Reaching midlife and older smokers: tailored interventions for routine medical care. , 1996, Preventive medicine.

[29]  B. Pollock,et al.  Pharmacokinetics of Single‐ and Multiple‐Dose Bupropion in Elderly Patients with Depression , 1995, Journal of clinical pharmacology.

[30]  Yuzo Sato,et al.  Daily Walking Combined With Diet Therapy Is a Useful Means for Obese NIDDM Patients Not Only to Reduce Body Weight But Also to Improve Insulin Sensitivity , 1995, Diabetes Care.

[31]  B. Rimer,et al.  Tailoring smoking cessation for older adults , 1994, Cancer.

[32]  B. Rosner,et al.  Predictors of smoking relapse among self-quitters: a report from the Normative Aging Study. , 1992, Addictive behaviors.

[33]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[34]  A. LaCroix,et al.  Smoking and mortality among older men and women in three communities. , 1991, The New England journal of medicine.

[35]  N. Vetter,et al.  Smoking prevention among people aged 60 and over: a randomized controlled trial. , 1990, Age and ageing.

[36]  S. Hall,et al.  Commitment to abstinence and acute stress in relapse to alcohol, opiates, and nicotine. , 1990, Journal of consulting and clinical psychology.

[37]  B. Rimer,et al.  The Older Smoker: Status, Challenges and Opportunities for Intervention , 1990 .

[38]  T. Kamarck,et al.  A global measure of perceived stress. , 1983, Journal of health and social behavior.

[39]  R. Mermelstein,et al.  Partner support and relapse in smoking-cessation programs. , 1983, Journal of consulting and clinical psychology.

[40]  P. Lewinsohn,et al.  Nonspecific improvement effects in depression using interpersonal skills training, pleasant activity schedules, or cognitive training. , 1979, Journal of Consulting and Clinical Psychology.

[41]  Thomas E Novotny,et al.  US Department of Health and Human Services: a need for global health leadership in preparedness and health diplomacy. , 2006, American journal of public health.

[42]  S. Levitus,et al.  US Government Printing Office , 1998 .

[43]  G. Gustavsson,et al.  Combined use of nicotine patch and gum in smoking cessation: a placebo-controlled clinical trial. , 1995, Preventive medicine.

[44]  Ware J.E.Jr.,et al.  THE MOS 36- ITEM SHORT FORM HEALTH SURVEY (SF- 36) CONCEPTUAL FRAMEWORK AND ITEM SELECTION , 1992 .

[45]  L. Leveton,et al.  Task Force 3: Patterns of smoking relapse. , 1986 .

[46]  L. Leveton,et al.  Patterns of smoking relapse. , 1986, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.

[47]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.